Just Other Articles
#1 in Business Subscribe Email Print

You are here: Home > Business > Strategic Planning > In the Kill Zone

Tags

  • fully
  • pandemic
  • market
  • total population
  • novel avian

  • Links

  • Hair Loss Defined And Treatments That Work
  • Having an Overall Feeling of Tiredness When Start Taking Viagra
  • Living With Prostate Cancer
  • Just Other Articles - In the Kill Zone

    Imagine arriving at work and two-thirds of your employees are out sick. Now imagine that you are the manager of a large supermarket or a Wal-mart a Super Target. This is exactly the situation that America's retailers and manufacturers
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    face with the coming avian flu pandemic.

    The avian flu will be a novel virus, one never seen before by the human immune system. The current disease of concern is the H5:N1 strain of avian flu. However, any novel avian flu will have
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    he same effect as was seen in 1918. In 1918, one-third of the United States population fell ill. Half of these sick individuals required some form of institutional care (hospital, infirmary, or quarantined home care). Of those in ins
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    titutional care, half developed severe pneumonia and half of those with pneumonia died. In short, 33% got of the total population sick and 8% of the total population died.

    When these ominous numbers were scrutinized further, a far more
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    dire picture evolved. Research into the 1918 pandemic, as well as pandemics before and since 1918, have shown that the majority of illness and death occurred not in the very old or the very young, not in the sick and infirm, but in tho
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    se who are in the "prime of life"; those age 18 to 40.

    Because of the way that novel avian viruses (pandemics) attack the lungs and cause "immune system storms", the ultimate irony of a pandemic is that the younger and stronger you are
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    the more likely you are to die. In 1918 fully two-thirds of all those who became ill were in the age range of 18 to 40. More distressing is the fact that 98 percent of all of those who died were age 18 to 40 years. In fact, those ove
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    r age 55 had no greater rate of illness or death during the pandemic of 1918 than they did in any other flu season in the years immediately before or after that great pandemic. Similarly, those less than 18 years of age suffered no inc
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    ease in death rate.

    The implications for America's retailers and America's manufacturers are inescapable. Fully two-thirds of the active workforce will fall ill during the 16 to 18 months of the disease throughout the pandemic. Twent
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    y-five percent of the young workforce (the 18 to 40 years) will die in that 18 months. Who will replace them? Where will American industry, America's retail sector, and American business find employees?

    America's employers have becom
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    accustomed to a ready workforce. If an employer finds that they have a job vacancy, no worries! They have become complacent knowing that they can readily replace an employee with the help of such services as Monster.com and other job-
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    atching tools. Take away 25 percent of the workforce due to death and two-thirds of workforce due to illness and you will see a dramatic shift in the balance of the employer-employee relationship. When there are not enough employees,
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    salaries will rise, prices will rise, and customer service will fall.

    The solution? Plan now.

    1. Those of us who have sought jobs are all too familiar with the refrain: "I'll keep your resume on file." Now employers must do exactly
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    hat. This is the time for employers to not only develop a ready pool of applicants, but to stay in touch with them in the same way that they stay in touch with their most valued customers. Employees will find other jobs in the interim
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    , but when employees become scarce, it is the employers who have shown a genuine interest in the person and the success of perspective employees who will prevail when the bidding wars begin.

    2. Hire now across a spectrum of ages. Many
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    employers concentrate their workforce in certain demographic age groups because they believe that their customers will identify better with these demographics or because of an age-based bias that convinces the employer that certain empl
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    oyees are better suited to certain work, certain work environments, or represent greater or lesser degrees of reliability. The coming pandemic lends a new variable to which employers must adapt. Employees less than 18 years of age and
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    greater than 55 years of age are less likely to be ill during the pandemic and less likely to die. Providing a more homogonous mix of employee ages will statistically decrease the impacts of the pandemic on the wise employer's workplac
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    e.

    3. Finally, workplace health promotion programs and health benefits, as well as a strict adherence to hygiene and clean workplaces will decrease the impact of the pandemic on the employees, the workforce, the employer and ultimately
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    the place of business.

    We cannot avoid the coming pandemic. We cannot avoid the coming impact on men and women alike, old and young alike, rich and poor alike. But we can prepare now, we can make our jobs and our workforces resilient


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.justotherarticles.org.ua/article/44532/justotherarticles-In-the-Kill-Zone.html">In the Kill Zone</a>

    BB link (for phorums):
    [url=http://www.justotherarticles.org.ua/article/44532/justotherarticles-In-the-Kill-Zone.html]In the Kill Zone[/url]

    Related Articles:

    More About Job Interview Questions

    When, Why, and How You Should Carry Out a Media Audit

    Is It Already Too Late?

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com